Patent ruling won't alter Empire Genomics approach

A Buffalo biotech firm says the U.S. Supreme Court decision this week on patents and genetics won’t likely have a major impact on its business, but the ruling does provide some clarity...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.